Pediatrics News

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

The CDC posted an alert in October about an increase in Mycoplasma pneumoniae, or “walking pneumonia,” infections in the United States, especially among young children.

Low-level lead poisoning remains prevalent across the United States and globally, warranting screening and identification of those at highest risk, according to a recently published review.

Infection prevention staff at Boston Children’s Hospital learned that the complexity of certain tasks is an important factor for determining staffing needs, rather than just using the number of beds.

Most children who did not receive antibiotics for pneumonia did not experience treatment failure or severe outcomes, according to study findings published in JAMA Network Open.

Young children who were exposed to cannabis before birth performed worse at executive functioning tasks and were more prone to aggressive behavior, according to findings from a small study published in JAMA Pediatrics.

Only one in five youth aged 6 to 17 years is meeting national physical activity recommendations, and that number has not increased in the last decade, according to the Physical Activity Alliance’s 2024 United States Report Card.

SAN ANTONIO — Higher concentrations of some phthalate and plasticizer metabolites were associated with higher odds of metabolic syndrome in U.S. adolescents and young adults, according to an analysis presented at ObesityWeek.

Most adolescents and young adults said they would hesitate to share sensitive information with their health care providers if they thought their parents could access it through online patients portals, according to a survey.

LOS ANGELES —In this video from IDWeek, Vani Vannappagari, MBBS, PhD, MPH, global head of epidemiology and real-world evidence at ViiV Healthcare, discusses study findings demonstrating the effectiveness of cabotegravir for HIV prevention.